Defining the minimal clinically important difference (MCID) of the Heinrichs-carpenter quality of life scale (QLS)Bruno Falissard, Karina Hansen, Christophe Sapin et al.|International Journal of Methods in Psychiatric Research|2015Cited by 33
O23 Ixekizumab (IXE) vs. adalimumab (ADA) for the treatment of PSA: 52-week efficacy and safety outcomesChristopher J Edwards, Soyi Liu Leage, Christophe Sapin et al.|Lara D. Veeken|2020Cited by 2